R H Creech - JoVE Visualize

Showing results (11-20 of 36) with videos related to

Pageof 4

Sort By:

JAMA|June 26, 1991

Exaggerated radiation-induced fibrosis in patients with systemic sclerosisJ Varga, U F Haustein, R H Creech, et al.

Cancer Treatment Reports|November 1, 1984

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV)J C Ruckdeschel, R Day, C H Weissman, et al.

Cancer Treatment Reports|November 1, 1981

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMPJ C Ruckdeschel, C R Mehta, O M Salazar, et al.

Cancer Treatment Reports|January 1, 1979

Phase II study of ICRF-159 in refractory metastatic breast cancerR H Creech, P F Engstrom, D T Harris, et al.

Cancer|January 1, 1979

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycinR H Creech, R B Catalano, D T Harris, et al.

Cancer Treatment Reports|November 1, 1985

Phase II study of low-dose mitomycin in patients with ovarian cancer previously treated with chemotherapyR H Creech, M K Shah, R B Catalano, et al.

Cancer Treatment Reports|June 1, 1982

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578)R H Creech, K Stanley, S E Vogl, et al.

Cancer|February 15, 1980

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trialJ H Glick, R H Creech, S Torri, et al.

Cancer Treatment Reports|September 1, 1985

Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposideP Bonomi, W O'Reilly, S E Vogl, et al.

Breast Cancer Research and Treatment|January 1, 1981

Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancerJ H Glick, R H Creech, S Torri, et al.

Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:

Pageof 4

JAMA|June 26, 1991

Exaggerated radiation-induced fibrosis in patients with systemic sclerosisJ Varga, U F Haustein, R H Creech, et al.

Cancer Treatment Reports|November 1, 1984

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV)J C Ruckdeschel, R Day, C H Weissman, et al.

Cancer Treatment Reports|November 1, 1981

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMPJ C Ruckdeschel, C R Mehta, O M Salazar, et al.

Cancer Treatment Reports|January 1, 1979

Phase II study of ICRF-159 in refractory metastatic breast cancerR H Creech, P F Engstrom, D T Harris, et al.

Cancer|January 1, 1979

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycinR H Creech, R B Catalano, D T Harris, et al.

Cancer Treatment Reports|November 1, 1985

Phase II study of low-dose mitomycin in patients with ovarian cancer previously treated with chemotherapyR H Creech, M K Shah, R B Catalano, et al.

Cancer Treatment Reports|June 1, 1982

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578)R H Creech, K Stanley, S E Vogl, et al.

Cancer|February 15, 1980

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trialJ H Glick, R H Creech, S Torri, et al.

Cancer Treatment Reports|September 1, 1985

Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposideP Bonomi, W O'Reilly, S E Vogl, et al.

Breast Cancer Research and Treatment|January 1, 1981

Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancerJ H Glick, R H Creech, S Torri, et al.

Pageof 4